

Instance: Amlodipin-AB-tabl-10-mg-0-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1302"
* subject = Reference(Amlodipin-AB-tabl-10-mg-0-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1302-Aurobindo)



Instance: Amlodipin-AB-tabl-10-mg-1-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1302"
* subject = Reference(Amlodipin-AB-tabl-10-mg-1-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1302-Aurobindo)



Instance: Amlodipin-Sandoz-Impexeco-tabl-deelb-Besilaat-10-m-2-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1307"
* subject = Reference(Amlodipin-Sandoz-Impexeco-tabl-deelb-Besilaat-10-m-2-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1307-Impexeco)



Instance: Amlodipin-Sandoz-tabl-deelb-Besilaat-10-mg-3-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1308"
* subject = Reference(Amlodipin-Sandoz-tabl-deelb-Besilaat-10-mg-3-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1308-Sandoz)



Instance: Amlodipin-Sandoz-tabl-deelb-Besilaat-10-mg-4-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1308"
* subject = Reference(Amlodipin-Sandoz-tabl-deelb-Besilaat-10-mg-4-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1308-Sandoz)



Instance: Amlodipin-Sandoz-tabl-deelb-Besilaat-10-mg-5-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1308"
* subject = Reference(Amlodipin-Sandoz-tabl-deelb-Besilaat-10-mg-5-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1308-Sandoz)



Instance: Amlodipine-EG-PIP-tabl-deelb-Besilate-10-mg-6-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1303"
* subject = Reference(Amlodipine-EG-PIP-tabl-deelb-Besilate-10-mg-6-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1303-PI-Pharma)



Instance: Amlodipine-EG-tabl-deelb-Besilate-10-mg-7-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1304"
* subject = Reference(Amlodipine-EG-tabl-deelb-Besilate-10-mg-7-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1304-EG)



Instance: Amlodipine-EG-tabl-deelb-Besilate-10-mg-8-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1304"
* subject = Reference(Amlodipine-EG-tabl-deelb-Besilate-10-mg-8-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1304-EG)



Instance: Amlodipine-Mylan-tabl-deelb-Besilate-10-mg-9-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1305"
* subject = Reference(Amlodipine-Mylan-tabl-deelb-Besilate-10-mg-9-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1305-Mylan)



Instance: Amlodipine-Teva-tabl-deelb-10-mg-10-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1306"
* subject = Reference(Amlodipine-Teva-tabl-deelb-10-mg-10-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1306-Teva)



Instance: Amlodipine-Teva-tabl-deelb-10-mg-11-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1306"
* subject = Reference(Amlodipine-Teva-tabl-deelb-10-mg-11-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1306-Teva)



Instance: Amlor-harde-caps-10-mg-12-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1300"
* subject = Reference(Amlor-harde-caps-10-mg-12-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1300-Upjohn)



Instance: Amlor-harde-caps-10-mg-13-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1300"
* subject = Reference(Amlor-harde-caps-10-mg-13-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1300-Upjohn)



Instance: Amlor-harde-caps-10-mg-14-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1300"
* subject = Reference(Amlor-harde-caps-10-mg-14-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1300-Upjohn)



Instance: Amlodipin-AB-tabl-5-mg-15-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1311"
* subject = Reference(Amlodipin-AB-tabl-5-mg-15-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1311-Aurobindo)



Instance: Amlodipin-AB-tabl-5-mg-16-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1311"
* subject = Reference(Amlodipin-AB-tabl-5-mg-16-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1311-Aurobindo)



Instance: Amlodipin-Sandoz-tabl-deelb-Besilaat-5-mg-17-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1316"
* subject = Reference(Amlodipin-Sandoz-tabl-deelb-Besilaat-5-mg-17-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1316-Sandoz)



Instance: Amlodipin-Sandoz-tabl-deelb-Besilaat-5-mg-18-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1316"
* subject = Reference(Amlodipin-Sandoz-tabl-deelb-Besilaat-5-mg-18-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1316-Sandoz)



Instance: Amlodipin-Sandoz-tabl-deelb-Besilaat-5-mg-19-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1316"
* subject = Reference(Amlodipin-Sandoz-tabl-deelb-Besilaat-5-mg-19-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1316-Sandoz)



Instance: Amlodipin-Sandoz-tabl-deelb-Besilaat-5-mg-20-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1316"
* subject = Reference(Amlodipin-Sandoz-tabl-deelb-Besilaat-5-mg-20-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1316-Sandoz)



Instance: Amlodipine-EG-tabl-Besilate-5-mg-21-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1312"
* subject = Reference(Amlodipine-EG-tabl-Besilate-5-mg-21-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1312-EG)



Instance: Amlodipine-EG-tabl-Besilate-5-mg-22-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1312"
* subject = Reference(Amlodipine-EG-tabl-Besilate-5-mg-22-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1312-EG)



Instance: Amlodipine-Mylan-tabl-deelb-Besilate-5-mg-23-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1313"
* subject = Reference(Amlodipine-Mylan-tabl-deelb-Besilate-5-mg-23-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1313-Mylan)



Instance: Amlodipine-Mylan-tabl-deelb-Besilate-5-mg-24-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1313"
* subject = Reference(Amlodipine-Mylan-tabl-deelb-Besilate-5-mg-24-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1313-Mylan)



Instance: Amlodipine-Teva-tabl-deelb-5-mg-25-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1314"
* subject = Reference(Amlodipine-Teva-tabl-deelb-5-mg-25-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1314-Teva)



Instance: Amlodipine-Teva-tabl-deelb-5-mg-26-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1314"
* subject = Reference(Amlodipine-Teva-tabl-deelb-5-mg-26-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1314-Teva)



Instance: Amlodipine-Teva-tabl-deelb-5-mg-27-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1314"
* subject = Reference(Amlodipine-Teva-tabl-deelb-5-mg-27-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1314-Teva)



Instance: Amlor-harde-caps-5-mg-28-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1309"
* subject = Reference(Amlor-harde-caps-5-mg-28-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1309-Upjohn)



Instance: Amlor-harde-caps-5-mg-29-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1309"
* subject = Reference(Amlor-harde-caps-5-mg-29-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1309-Upjohn)



Instance: Amlor-harde-caps-5-mg-30-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1309"
* subject = Reference(Amlor-harde-caps-5-mg-30-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1309-Upjohn)



Instance: Amlor-harde-caps-5-mg-31-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1309"
* subject = Reference(Amlor-harde-caps-5-mg-31-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1309-Upjohn)



Instance: Amlodipine-Belisate-Mylan-10-mg-32-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1447"
* subject = Reference(Amlodipine-Belisate-Mylan-10-mg-32-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1447-Mylan-EPD)



Instance: Amlogal-Divule-omh-tabl-10-mg-33-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1212"
* subject = Reference(Amlogal-Divule-omh-tabl-10-mg-33-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1212-SMB)



Instance: Amlogal-Divule-omh-tabl-10-mg-34-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1212"
* subject = Reference(Amlogal-Divule-omh-tabl-10-mg-34-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1212-SMB)



Instance: Amlodipine-Krka-tabl-10-mg-35-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "9200"
* subject = Reference(Amlodipine-Krka-tabl-10-mg-35-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-9200-Krka)



Instance: Amlodipine-Krka-tabl-10-mg-36-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "9200"
* subject = Reference(Amlodipine-Krka-tabl-10-mg-36-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-9200-Krka)



Instance: Amlodipine-Krka-tabl-5-mg-37-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "9200"
* subject = Reference(Amlodipine-Krka-tabl-5-mg-37-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-9200-Krka)



Instance: Amlodipine-Krka-tabl-5-mg-38-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "9200"
* subject = Reference(Amlodipine-Krka-tabl-5-mg-38-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-9200-Krka)



Instance: Amlodipine-Krka-tabl-5-mg-39-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "9200"
* subject = Reference(Amlodipine-Krka-tabl-5-mg-39-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-9200-Krka)



Instance: Tegretol-tabl-geregul-afgifte-deelb-CR-200-mg-40-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1355"
* subject = Reference(Tegretol-tabl-geregul-afgifte-deelb-CR-200-mg-40-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1355-Novartis-Pharma)



Instance: Tegretol-tabl-geregul-afgifte-deelb-CR-400-mg-41-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1357"
* subject = Reference(Tegretol-tabl-geregul-afgifte-deelb-CR-400-mg-41-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1357-Novartis-Pharma)



Instance: Tegretol-siroop-susp-100-mg-5-ml-42-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1357"
* subject = Reference(Tegretol-siroop-susp-100-mg-5-ml-42-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1357-Novartis-Pharma)



Instance: Tegretol-tabl-deelb-200-mg-43-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1356"
* subject = Reference(Tegretol-tabl-deelb-200-mg-43-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1356-Novartis-Pharma)



Instance: Extrapan-5-transderm-lok-gel-50-mg-1-g-44-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1437"
* subject = Reference(Extrapan-5-transderm-lok-gel-50-mg-1-g-44-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1437-Qualiphar)



Instance: Ibuprofen-Kela-5-transderm-lok-gel-50-mg-1-g-45-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1438"
* subject = Reference(Ibuprofen-Kela-5-transderm-lok-gel-50-mg-1-g-45-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1438-Kela)



Instance: Ibuprofen-Teva-5-transderm-lok-gel-50-mg-1-g-46-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1439"
* subject = Reference(Ibuprofen-Teva-5-transderm-lok-gel-50-mg-1-g-46-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1439-Teva)



Instance: Ibuprofen-Teva-5-transderm-lok-gel-50-mg-1-g-47-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1439"
* subject = Reference(Ibuprofen-Teva-5-transderm-lok-gel-50-mg-1-g-47-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1439-Teva)



Instance: Pedea-inf-oploss-i-v-amp-10-mg-2-ml-48-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "2519"
* subject = Reference(Pedea-inf-oploss-i-v-amp-10-mg-2-ml-48-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-2519-Recordati)



Instance: Ibuprofen-B-Braun-inf-oploss-i-v-flac-200-mg-50-ml-49-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "3534"
* subject = Reference(Ibuprofen-B-Braun-inf-oploss-i-v-flac-200-mg-50-ml-49-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-3534-B-Braun)



Instance: Ibuprofen-B-Braun-inf-oploss-i-v-flac-400-mg-100-m-50-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "3534"
* subject = Reference(Ibuprofen-B-Braun-inf-oploss-i-v-flac-400-mg-100-m-50-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-3534-B-Braun)



Instance: Ibuprofen-B-Braun-inf-oploss-i-v-flac-600-mg-100-m-51-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "3534"
* subject = Reference(Ibuprofen-B-Braun-inf-oploss-i-v-flac-600-mg-100-m-51-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-3534-B-Braun)



Instance: Brufen-tabl-verl-afgifte-Retard-800-mg-52-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1447"
* subject = Reference(Brufen-tabl-verl-afgifte-Retard-800-mg-52-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1447-Mylan-EPD)



Instance: Brufen-tabl-verl-afgifte-Retard-800-mg-53-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1447"
* subject = Reference(Brufen-tabl-verl-afgifte-Retard-800-mg-53-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1447-Mylan-EPD)



Instance: Ibuprofen-EG-tabl-verl-afgifte-800-mg-54-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1448"
* subject = Reference(Ibuprofen-EG-tabl-verl-afgifte-800-mg-54-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1448-EG)



Instance: Ibuprofen-EG-tabl-verl-afgifte-800-mg-55-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1448"
* subject = Reference(Ibuprofen-EG-tabl-verl-afgifte-800-mg-55-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1448-EG)



Instance: Nurofen-zachte-kauwcaps-Kinderen-100-mg-56-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1417"
* subject = Reference(Nurofen-zachte-kauwcaps-Kinderen-100-mg-56-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1417-Reckitt-Benckiser)



Instance: Algidrin-siroop-susp-100-mg-5-ml-57-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1412"
* subject = Reference(Algidrin-siroop-susp-100-mg-5-ml-57-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1412-I-D-Phar)



Instance: Nurofen-2-siroop-susp-zonder-suiker-Kinderen-100-m-58-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1414"
* subject = Reference(Nurofen-2-siroop-susp-zonder-suiker-Kinderen-100-m-58-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1414-Reckitt-Benckiser)



Instance: Nurofen-2-siroop-susp-zonder-suiker-Rood-Kinderen--59-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1415"
* subject = Reference(Nurofen-2-siroop-susp-zonder-suiker-Rood-Kinderen--59-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1415-Reckitt-Benckiser)



Instance: Perdophen-2-siroop-susp-100-mg-5-ml-60-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1416"
* subject = Reference(Perdophen-2-siroop-susp-100-mg-5-ml-60-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1416-Johnson-Johnson-Consumer)



Instance: Ibuprofen-EG-omh-tabl-200-mg-61-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1425"
* subject = Reference(Ibuprofen-EG-omh-tabl-200-mg-61-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1425-EG)



Instance: Ibuprofen-Sandoz-filmomh-tabl-200-mg-62-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1426"
* subject = Reference(Ibuprofen-Sandoz-filmomh-tabl-200-mg-62-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1426-Sandoz)



Instance: Nurofen-omh-tabl-200-mg-63-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1427"
* subject = Reference(Nurofen-omh-tabl-200-mg-63-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1427-Reckitt-Benckiser)



Instance: Nurofen-omh-tabl-200-mg-64-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1427"
* subject = Reference(Nurofen-omh-tabl-200-mg-64-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1427-Reckitt-Benckiser)



Instance: Nurofen-omh-tabl-Kinderen-200-mg-65-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1428"
* subject = Reference(Nurofen-omh-tabl-Kinderen-200-mg-65-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1428-Reckitt-Benckiser)



Instance: Spidifen-oploss-gran-zakjes-200-mg-66-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "135"
* subject = Reference(Spidifen-oploss-gran-zakjes-200-mg-66-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-135-Zambon)



Instance: Brufen-siroop-susp-200-mg-5-ml-67-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1419"
* subject = Reference(Brufen-siroop-susp-200-mg-5-ml-67-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1419-Mylan-EPD)



Instance: Ibuprofen-EG-siroop-susp-200-mg-5-ml-68-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1420"
* subject = Reference(Ibuprofen-EG-siroop-susp-200-mg-5-ml-68-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1420-EG)



Instance: Nurofen-4-siroop-susp-zonder-suiker-Kinderen-200-m-69-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1421"
* subject = Reference(Nurofen-4-siroop-susp-zonder-suiker-Kinderen-200-m-69-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1421-Reckitt-Benckiser)



Instance: Nurofen-4-siroop-susp-zonder-suiker-Rood-Kinderen--70-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1422"
* subject = Reference(Nurofen-4-siroop-susp-zonder-suiker-Rood-Kinderen--70-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1422-Reckitt-Benckiser)



Instance: Brufen-filmomh-tabl-400-mg-71-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1431"
* subject = Reference(Brufen-filmomh-tabl-400-mg-71-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1431-Mylan-EPD)



Instance: Brufen-filmomh-tabl-400-mg-72-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1431"
* subject = Reference(Brufen-filmomh-tabl-400-mg-72-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1431-Mylan-EPD)



Instance: Brufen-filmomh-tabl-400-mg-73-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1431"
* subject = Reference(Brufen-filmomh-tabl-400-mg-73-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1431-Mylan-EPD)



Instance: Ibuprofen-EG-omh-tabl-deelb-400-mg-74-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1432"
* subject = Reference(Ibuprofen-EG-omh-tabl-deelb-400-mg-74-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1432-EG)



Instance: Ibuprofen-EG-omh-tabl-deelb-400-mg-75-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1432"
* subject = Reference(Ibuprofen-EG-omh-tabl-deelb-400-mg-75-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1432-EG)



Instance: Ibuprofen-Sandoz-filmomh-tabl-deelb-400-mg-76-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1433"
* subject = Reference(Ibuprofen-Sandoz-filmomh-tabl-deelb-400-mg-76-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1433-Sandoz)



Instance: Ibuprofen-Sandoz-filmomh-tabl-deelb-400-mg-77-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1433"
* subject = Reference(Ibuprofen-Sandoz-filmomh-tabl-deelb-400-mg-77-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1433-Sandoz)



Instance: Nurofen-PIP-zachte-caps-Fastcaps-400-mg-78-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1429"
* subject = Reference(Nurofen-PIP-zachte-caps-Fastcaps-400-mg-78-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1429-PI-Pharma)



Instance: Nurofen-PIP-zachte-caps-Fastcaps-400-mg-79-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1429"
* subject = Reference(Nurofen-PIP-zachte-caps-Fastcaps-400-mg-79-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1429-PI-Pharma)



Instance: Nurofen-filmomh-tabl-Fasttabs-400-mg-80-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1434"
* subject = Reference(Nurofen-filmomh-tabl-Fasttabs-400-mg-80-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1434-Reckitt-Benckiser)



Instance: Nurofen-omh-tabl-400-mg-81-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1435"
* subject = Reference(Nurofen-omh-tabl-400-mg-81-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1435-Reckitt-Benckiser)



Instance: Nurofen-zachte-caps-Fastcaps-400-mg-82-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1430"
* subject = Reference(Nurofen-zachte-caps-Fastcaps-400-mg-82-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1430-Reckitt-Benckiser)



Instance: Nurofen-zachte-caps-Fastcaps-400-mg-83-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1430"
* subject = Reference(Nurofen-zachte-caps-Fastcaps-400-mg-83-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1430-Reckitt-Benckiser)



Instance: Perdofemina-filmomh-tabl-400-mg-84-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1436"
* subject = Reference(Perdofemina-filmomh-tabl-400-mg-84-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1436-Johnson-Johnson-Consumer)



Instance: Spidifen-filmomh-tabl-deelb-400-mg-85-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "135"
* subject = Reference(Spidifen-filmomh-tabl-deelb-400-mg-85-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-135-Zambon)



Instance: Brufen-bruisgran-zakjes-600-mg-86-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1441"
* subject = Reference(Brufen-bruisgran-zakjes-600-mg-86-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1441-Mylan-EPD)



Instance: Brufen-filmomh-tabl-Forte-600-mg-87-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1442"
* subject = Reference(Brufen-filmomh-tabl-Forte-600-mg-87-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1442-Mylan-EPD)



Instance: Brufen-filmomh-tabl-Forte-600-mg-88-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1442"
* subject = Reference(Brufen-filmomh-tabl-Forte-600-mg-88-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1442-Mylan-EPD)



Instance: Ibuprofen-AB-filmomh-tabl-deelb-600-mg-89-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1443"
* subject = Reference(Ibuprofen-AB-filmomh-tabl-deelb-600-mg-89-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1443-Aurobindo)



Instance: Ibuprofen-AB-filmomh-tabl-deelb-600-mg-90-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1443"
* subject = Reference(Ibuprofen-AB-filmomh-tabl-deelb-600-mg-90-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1443-Aurobindo)



Instance: Ibuprofen-EG-omh-tabl-deelb-600-mg-91-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1444"
* subject = Reference(Ibuprofen-EG-omh-tabl-deelb-600-mg-91-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1444-EG)



Instance: Ibuprofen-EG-omh-tabl-deelb-600-mg-92-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1444"
* subject = Reference(Ibuprofen-EG-omh-tabl-deelb-600-mg-92-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1444-EG)



Instance: Ibuprofen-Sandoz-filmomh-tabl-deelb-600-mg-93-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1445"
* subject = Reference(Ibuprofen-Sandoz-filmomh-tabl-deelb-600-mg-93-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1445-Sandoz)



Instance: Ibuprofen-Sandoz-filmomh-tabl-deelb-600-mg-94-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1445"
* subject = Reference(Ibuprofen-Sandoz-filmomh-tabl-deelb-600-mg-94-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1445-Sandoz)



Instance: Ibuprofen-AB-filmomh-tabl-deelb-800-mg-95-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1449"
* subject = Reference(Ibuprofen-AB-filmomh-tabl-deelb-800-mg-95-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1449-Aurobindo)



Instance: Ibuprofen-AB-filmomh-tabl-deelb-800-mg-96-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1449"
* subject = Reference(Ibuprofen-AB-filmomh-tabl-deelb-800-mg-96-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1449-Aurobindo)



Instance: Ibuprofen-AB-filmomh-tabl-deelb-800-mg-97-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1449"
* subject = Reference(Ibuprofen-AB-filmomh-tabl-deelb-800-mg-97-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1449-Aurobindo)



Instance: Nurofen-Patch-transderm-lok-medic-pleister-200-mg--98-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1424"
* subject = Reference(Nurofen-Patch-transderm-lok-medic-pleister-200-mg--98-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1424-Reckitt-Benckiser)



Instance: Nurofen-zetpil-Kinderen-125-mg-99-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1418"
* subject = Reference(Nurofen-zetpil-Kinderen-125-mg-99-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1418-Reckitt-Benckiser)



Instance: Nurofen-zetpil-Kinderen-60-mg-100-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1446"
* subject = Reference(Nurofen-zetpil-Kinderen-60-mg-100-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1446-Reckitt-Benckiser)



Instance: Nurofen-200-Fastcaps-200-mg-zachte-caps-2-101-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1446"
* subject = Reference(Nurofen-200-Fastcaps-200-mg-zachte-caps-2-101-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1446-Reckitt-Benckiser)



Instance: Ibuprofen-AB-200-mg-filmomh-tabl-24-102-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1559"
* subject = Reference(Ibuprofen-AB-200-mg-filmomh-tabl-24-102-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1559-Aurobindo)



Instance: Ibuprofen-AB-400-mg-filmomh-tabl-24-103-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1559"
* subject = Reference(Ibuprofen-AB-400-mg-filmomh-tabl-24-103-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1559-Aurobindo)



Instance: Cholemed-filmomh-tabl-deelb-20-mg-104-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1558"
* subject = Reference(Cholemed-filmomh-tabl-deelb-20-mg-104-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1558-Amophar)



Instance: simvastatine-AB-filmomh-tabl-20-mg-105-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1559"
* subject = Reference(simvastatine-AB-filmomh-tabl-20-mg-105-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1559-Aurobindo)



Instance: simvastatine-AB-filmomh-tabl-20-mg-106-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1559"
* subject = Reference(simvastatine-AB-filmomh-tabl-20-mg-106-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1559-Aurobindo)



Instance: simvastatine-Sandoz-Impexeco-filmomh-tabl-deelb-20-107-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1564"
* subject = Reference(simvastatine-Sandoz-Impexeco-filmomh-tabl-deelb-20-107-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1564-Impexeco)



Instance: simvastatine-Sandoz-filmomh-tabl-deelb-20-mg-108-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1563"
* subject = Reference(simvastatine-Sandoz-filmomh-tabl-deelb-20-mg-108-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1563-Sandoz)



Instance: simvastatine-Sandoz-filmomh-tabl-deelb-20-mg-109-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1563"
* subject = Reference(simvastatine-Sandoz-filmomh-tabl-deelb-20-mg-109-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1563-Sandoz)



Instance: simvastatine-Sandoz-filmomh-tabl-deelb-20-mg-110-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1563"
* subject = Reference(simvastatine-Sandoz-filmomh-tabl-deelb-20-mg-110-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1563-Sandoz)



Instance: simvastine-EG-filmomh-tabl-deelb-20-mg-111-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1560"
* subject = Reference(simvastine-EG-filmomh-tabl-deelb-20-mg-111-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1560-EG)



Instance: simvastine-EG-filmomh-tabl-deelb-20-mg-112-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1560"
* subject = Reference(simvastine-EG-filmomh-tabl-deelb-20-mg-112-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1560-EG)



Instance: simvastine-EG-filmomh-tabl-deelb-20-mg-113-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1560"
* subject = Reference(simvastine-EG-filmomh-tabl-deelb-20-mg-113-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1560-EG)



Instance: simvastine-Mylan-filmomh-tabl-deelb-20-mg-114-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1561"
* subject = Reference(simvastine-Mylan-filmomh-tabl-deelb-20-mg-114-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1561-Mylan)



Instance: simvastine-Mylan-filmomh-tabl-deelb-20-mg-115-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1561"
* subject = Reference(simvastine-Mylan-filmomh-tabl-deelb-20-mg-115-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1561-Mylan)



Instance: simvastine-Mylan-filmomh-tabl-deelb-20-mg-116-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1561"
* subject = Reference(simvastine-Mylan-filmomh-tabl-deelb-20-mg-116-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1561-Mylan)



Instance: simvastine-Teva-filmomh-tabl-deelb-20-mg-117-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1562"
* subject = Reference(simvastine-Teva-filmomh-tabl-deelb-20-mg-117-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1562-Teva)



Instance: simvastine-Teva-filmomh-tabl-deelb-20-mg-118-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1562"
* subject = Reference(simvastine-Teva-filmomh-tabl-deelb-20-mg-118-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1562-Teva)



Instance: Zocor-filmomh-tabl-20-mg-119-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1565"
* subject = Reference(Zocor-filmomh-tabl-20-mg-119-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1565-Organon)



Instance: Cholemed-filmomh-tabl-deelb-40-mg-120-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1566"
* subject = Reference(Cholemed-filmomh-tabl-deelb-40-mg-120-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1566-Amophar)



Instance: simvastatine-AB-filmomh-tabl-40-mg-121-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1567"
* subject = Reference(simvastatine-AB-filmomh-tabl-40-mg-121-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1567-Aurobindo)



Instance: simvastatine-AB-filmomh-tabl-40-mg-122-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1567"
* subject = Reference(simvastatine-AB-filmomh-tabl-40-mg-122-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1567-Aurobindo)



Instance: simvastatine-Sandoz-Impexeco-filmomh-tabl-deelb-40-123-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1573"
* subject = Reference(simvastatine-Sandoz-Impexeco-filmomh-tabl-deelb-40-123-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1573-Impexeco)



Instance: simvastatine-Sandoz-filmomh-tabl-deelb-40-mg-124-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1572"
* subject = Reference(simvastatine-Sandoz-filmomh-tabl-deelb-40-mg-124-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1572-Sandoz)



Instance: simvastatine-Sandoz-filmomh-tabl-deelb-40-mg-125-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1572"
* subject = Reference(simvastatine-Sandoz-filmomh-tabl-deelb-40-mg-125-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1572-Sandoz)



Instance: simvastatine-Sandoz-filmomh-tabl-deelb-40-mg-126-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1572"
* subject = Reference(simvastatine-Sandoz-filmomh-tabl-deelb-40-mg-126-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1572-Sandoz)



Instance: simvastine-EG-PIP-filmomh-tabl-deelb-40-mg-127-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1569"
* subject = Reference(simvastine-EG-PIP-filmomh-tabl-deelb-40-mg-127-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1569-PI-Pharma)



Instance: simvastine-EG-filmomh-tabl-deelb-40-mg-128-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1568"
* subject = Reference(simvastine-EG-filmomh-tabl-deelb-40-mg-128-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1568-EG)



Instance: simvastine-EG-filmomh-tabl-deelb-40-mg-129-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1568"
* subject = Reference(simvastine-EG-filmomh-tabl-deelb-40-mg-129-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1568-EG)



Instance: simvastine-EG-filmomh-tabl-deelb-40-mg-130-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1568"
* subject = Reference(simvastine-EG-filmomh-tabl-deelb-40-mg-130-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1568-EG)



Instance: simvastine-Mylan-filmomh-tabl-deelb-40-mg-131-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1570"
* subject = Reference(simvastine-Mylan-filmomh-tabl-deelb-40-mg-131-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1570-Mylan)



Instance: simvastine-Mylan-filmomh-tabl-deelb-40-mg-132-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1570"
* subject = Reference(simvastine-Mylan-filmomh-tabl-deelb-40-mg-132-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1570-Mylan)



Instance: simvastine-Mylan-filmomh-tabl-deelb-40-mg-133-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1570"
* subject = Reference(simvastine-Mylan-filmomh-tabl-deelb-40-mg-133-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1570-Mylan)



Instance: simvastine-Teva-filmomh-tabl-deelb-40-mg-134-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1571"
* subject = Reference(simvastine-Teva-filmomh-tabl-deelb-40-mg-134-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1571-Teva)



Instance: simvastine-Teva-filmomh-tabl-deelb-40-mg-135-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1571"
* subject = Reference(simvastine-Teva-filmomh-tabl-deelb-40-mg-135-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1571-Teva)



Instance: Zocor-filmomh-tabl-40-mg-136-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1574"
* subject = Reference(Zocor-filmomh-tabl-40-mg-136-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1574-Organon)



Instance: simvastatine-Sandoz-filmomh-tabl-deelb-80-mg-137-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1576"
* subject = Reference(simvastatine-Sandoz-filmomh-tabl-deelb-80-mg-137-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1576-Sandoz)



Instance: simvastine-Teva-filmomh-tabl-deelb-80-mg-138-BEL-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = "1575"
* subject = Reference(simvastine-Teva-filmomh-tabl-deelb-80-mg-138-BEL-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000337 "Kingdom of Belgium"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-1575-Teva)



Instance: NORVALET-CAPS-5MG-CAP-139-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORVALET-CAPS-5MG-CAP-139-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-INNOVIS-HEALTH-A-E-)



Instance: NORVALET-CAPS-10MG-CAP-140-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORVALET-CAPS-10MG-CAP-140-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-INNOVIS-HEALTH-A-E-)



Instance: FLODIL-CAPS-5MG-CAP-141-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(FLODIL-CAPS-5MG-CAP-141-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MINERBA-PhARMAKEUTIKE-A-E-)



Instance: FLODIL-CAPS-10MG-CAP-142-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(FLODIL-CAPS-10MG-CAP-142-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MINERBA-PhARMAKEUTIKE-A-E-)



Instance: AMLODIN-CAPS-5MG-CAP-143-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIN-CAPS-5MG-CAP-143-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BENNETT-PhARMAKEUTIKE-A-E-)



Instance: AMLODIN-CAPS-10MG-CAP-144-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIN-CAPS-10MG-CAP-144-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BENNETT-PhARMAKEUTIKE-A-E-)



Instance: AMLIBON-TAB-5MG-TAB-145-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLIBON-TAB-5MG-TAB-145-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-SANDOZ-GMBH-KUNDL-AUSTRIA)



Instance: AMLIBON-TAB-10MG-TAB-146-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLIBON-TAB-10MG-TAB-146-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-SANDOZ-GMBH-KUNDL-AUSTRIA)



Instance: AMODIPAN-CAPS-10MG-CAP-147-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMODIPAN-CAPS-10MG-CAP-147-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-SANTA-PHARMA-A-E-)



Instance: AMODIPAN-CAPS-5MG-CAP-148-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMODIPAN-CAPS-5MG-CAP-148-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-SANTA-PHARMA-A-E-)



Instance: PIDOLEN-GENOSEMO-CAPS-5MG-CAP-149-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PIDOLEN-GENOSEMO-CAPS-5MG-CAP-149-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PhARMEKs-A-E-)



Instance: PIDOLEN-GENOSEMO-CAPS-10MG-CAP-150-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PIDOLEN-GENOSEMO-CAPS-10MG-CAP-150-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PhARMEKs-A-E-)



Instance: AGGOVASK-CAPS-5MG-CAP-151-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AGGOVASK-CAPS-5MG-CAP-151-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PROTON-PHARMA-ANONUME-PhARMAKEUTIKE-ETAIREIA)



Instance: AGGOVASK-CAPS-10MG-CAP-BTx14-152-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AGGOVASK-CAPS-10MG-CAP-BTx14-152-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PROTON-PHARMA-ANONUME-PhARMAKEUTIKE-ETAIREIA)



Instance: LODIPIN-CAPS-5MG-CAP-153-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LODIPIN-CAPS-5MG-CAP-153-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-IASIS-PHARMA)



Instance: LODIPIN-CAPS-10MG-CAP-154-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LODIPIN-CAPS-10MG-CAP-154-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-IASIS-PHARMA)



Instance: LODIPIN-CAPS-10MG-CAP-155-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LODIPIN-CAPS-10MG-CAP-155-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-IASIS-PHARMA)



Instance: NORMODIN-TAB-5MG-TAB-156-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORMODIN-TAB-5MG-TAB-156-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENEPHARM-AE)



Instance: NORMODIN-TAB-10MG-TAB-157-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORMODIN-TAB-10MG-TAB-157-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENEPHARM-AE)



Instance: AMLIBON-BES-TAB-5MG-TAB-158-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLIBON-BES-TAB-5MG-TAB-158-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-SANDOZ-GMBH-KUNDL-AUSTRIA)



Instance: AMLIBON-BES-TAB-10MG-TAB-159-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLIBON-BES-TAB-10MG-TAB-159-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-SANDOZ-GMBH-KUNDL-AUSTRIA)



Instance: BARUDEN-CAPS-10MG-CAP-160-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(BARUDEN-CAPS-10MG-CAP-160-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ANPhARM-ELLAS-A-E-)



Instance: BARUDEN-CAPS-10MG-CAP-161-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(BARUDEN-CAPS-10MG-CAP-161-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ANPhARM-ELLAS-A-E-)



Instance: NORDEX-MEDICAL-PHARMAQUALITY-TAB-162-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORDEX-MEDICAL-PHARMAQUALITY-TAB-162-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDICAL-PHARMAQUALITY-AE)



Instance: NORDEX-MEDICAL-PHARMAQUALITY-TAB-163-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORDEX-MEDICAL-PHARMAQUALITY-TAB-163-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDICAL-PHARMAQUALITY-AE)



Instance: AMLORETIN-CAPS-10MG-CAP-164-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLORETIN-CAPS-10MG-CAP-164-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NATURALIA-A-E-)



Instance: AMLORETIN-CAPS-5MG-CAP-165-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLORETIN-CAPS-5MG-CAP-165-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NATURALIA-A-E-)



Instance: NORVASC-CAPS-5MG-CAP-166-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORVASC-CAPS-5MG-CAP-166-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-UPJOHN-HELLAS-E-P-E-)



Instance: NORVASC-CAPS-10MG-CAP-167-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORVASC-CAPS-10MG-CAP-167-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-UPJOHN-HELLAS-E-P-E-)



Instance: ALDOSION-CAPS-5MG-CAP-168-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ALDOSION-CAPS-5MG-CAP-168-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ALAPIS-ABEE)



Instance: ALDOSION-CAPS-10MG-CAP-169-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ALDOSION-CAPS-10MG-CAP-169-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ALAPIS-ABEE)



Instance: AMLODIPINE-MALEATE-GENERICS-TAB-170-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIPINE-MALEATE-GENERICS-TAB-170-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: amlodipine-maleate-GENERICS-TAB-5MG-TAB-171-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(amlodipine-maleate-GENERICS-TAB-5MG-TAB-171-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: amlodipine-maleate-GENERICS-TAB-10MG-TAB-172-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(amlodipine-maleate-GENERICS-TAB-10MG-TAB-172-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: amlodipine-maleate-GENERICS-TAB-10MG-TAB-173-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(amlodipine-maleate-GENERICS-TAB-10MG-TAB-173-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: EVANGIO-CAPS-5MG-CAP-174-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(EVANGIO-CAPS-5MG-CAP-174-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: AMLOPRESS-CAPS-5MG-CAP-175-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLOPRESS-CAPS-5MG-CAP-175-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-FOS-PhARMAKEUTIKE-IKE)



Instance: AMLOPRESS-CAPS-10-MG-CAP-176-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLOPRESS-CAPS-10-MG-CAP-176-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-FOS-PhARMAKEUTIKE-IKE)



Instance: AMLODIL-CAPS-10MG-CAP-177-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIL-CAPS-10MG-CAP-177-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GAP-A-E-)



Instance: NORFAN-CAPS-5MG-CAP-178-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORFAN-CAPS-5MG-CAP-178-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-VOCATE-PhARMAKEUTIKE-A-E-)



Instance: NORFAN-CAPS-5MG-CAP-179-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORFAN-CAPS-5MG-CAP-179-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-VOCATE-PhARMAKEUTIKE-A-E-)



Instance: NORFAN-CAPS-10MG-CAP-180-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORFAN-CAPS-10MG-CAP-180-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-VOCATE-PhARMAKEUTIKE-A-E-)



Instance: AXYPLOT-CAPS-5MG-CAP-181-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AXYPLOT-CAPS-5MG-CAP-181-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-IAMATICA-MON-EPE)



Instance: AXYPLOT-CAPS-10MG-CAP-182-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AXYPLOT-CAPS-10MG-CAP-182-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-IAMATICA-MON-EPE)



Instance: AMLOSILAT-CAPS-5MG-CAP-183-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLOSILAT-CAPS-5MG-CAP-183-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ALPHA-GENERICS-THERAPY-AEBEPh)



Instance: AMLOSILAT-CAPS-5MG-CAP-184-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLOSILAT-CAPS-5MG-CAP-184-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ALPHA-GENERICS-THERAPY-AEBEPh)



Instance: AMLOSILAT-CAPS-10-MG-CAP-185-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLOSILAT-CAPS-10-MG-CAP-185-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ALPHA-GENERICS-THERAPY-AEBEPh)



Instance: DAFOR-CAPS-5MG-CAP-186-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(DAFOR-CAPS-5MG-CAP-186-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PNG-GEROLUMATOS-MENTIKAL-A-E-)



Instance: DAFOR-CAPS-5MG-CAP-187-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(DAFOR-CAPS-5MG-CAP-187-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PNG-GEROLUMATOS-MENTIKAL-A-E-)



Instance: DAFOR-CAPS-10MG-CAP-188-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(DAFOR-CAPS-10MG-CAP-188-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PNG-GEROLUMATOS-MENTIKAL-A-E-)



Instance: DAFOR-CAPS-10MG-CAP-189-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(DAFOR-CAPS-10MG-CAP-189-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PNG-GEROLUMATOS-MENTIKAL-A-E-)



Instance: VASCODIN-CAPS-5MG-CAP-190-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASCODIN-CAPS-5MG-CAP-190-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-HELP-ABEE)



Instance: VASCODIN-CAPS-5MG-CAP-191-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASCODIN-CAPS-5MG-CAP-191-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-HELP-ABEE)



Instance: VASCODIN-CAPS-10MG-CAP-192-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASCODIN-CAPS-10MG-CAP-192-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-HELP-ABEE)



Instance: VASCODIN-CAPS-10MG-CAP-193-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASCODIN-CAPS-10MG-CAP-193-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-HELP-ABEE)



Instance: AMLODIPINE-BESILATE-NORMA-CAPS-5MG-CAP-194-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIPINE-BESILATE-NORMA-CAPS-5MG-CAP-194-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NORMA-ELLAS-A-E-)



Instance: AMLODIPINE-BESILATE-NORMA-CAPS-10MG-CAP-195-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIPINE-BESILATE-NORMA-CAPS-10MG-CAP-195-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NORMA-ELLAS-A-E-)



Instance: EVANGIO-CAPS-5MG-CAP-196-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(EVANGIO-CAPS-5MG-CAP-196-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: EVANGIO-CAPS-10MG-197-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(EVANGIO-CAPS-10MG-197-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: EVANGIO-CAPS-10MG-198-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(EVANGIO-CAPS-10MG-198-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: AMLODIPINE-BESILATE-TEVA-TAB-199-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIPINE-BESILATE-TEVA-TAB-199-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-TEVA-PHARMA-B-V-Haarlem-THE-NETHERLANDS)



Instance: AMLODIPINE-BESILATE-TEVA-TAB-5MG-TAB-200-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIPINE-BESILATE-TEVA-TAB-5MG-TAB-200-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-TEVA-PHARMA-B-V-Haarlem-THE-NETHERLANDS)



Instance: NOLVAC-TAB-10MG-TAB-201-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NOLVAC-TAB-10MG-TAB-201-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PhARMATEN-ELLAS-AEBE)



Instance: NOLVAC-TAB-10MG-TAB-202-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NOLVAC-TAB-10MG-TAB-202-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-INNOVIS-PHARMA-A-E-B-E)



Instance: ABESYL-CAPS-5MG-CAP-203-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ABESYL-CAPS-5MG-CAP-203-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDOCHEMIE-HELLAS-AE)



Instance: ABESYL-CAPS-10MG-CAP-204-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ABESYL-CAPS-10MG-CAP-204-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDOCHEMIE-HELLAS-AE)



Instance: ANGIORETIC-CAPS-5MG-CAP-205-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ANGIORETIC-CAPS-5MG-CAP-205-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDARTE-PhARMAKEUTIKE-ABEE)



Instance: ANGIORETIC-CAPS-10MG-CAP-206-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ANGIORETIC-CAPS-10MG-CAP-206-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDARTE-PhARMAKEUTIKE-ABEE)



Instance: PRECARDIN-CAPS-10MG-CAP-207-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRECARDIN-CAPS-10MG-CAP-207-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-FARMEDIA-AE)



Instance: PRECARDIN-CAPS-10MG-CAP-208-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRECARDIN-CAPS-10MG-CAP-208-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-FARMEDIA-AE)



Instance: AMLODIPINE-MYLAN-GENERICS-TAB-5MG-TAB-209-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIPINE-MYLAN-GENERICS-TAB-5MG-TAB-209-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: AMLODIPINE-MYLAN-GENERICS-TAB-10MG-TAB-210-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLODIPINE-MYLAN-GENERICS-TAB-10MG-TAB-210-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: ROVOXID-CAPS-5MG-CAP-211-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ROVOXID-CAPS-5MG-CAP-211-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BIAN-A-E-)



Instance: ROVOXID-CAPS-10MG-CAP-212-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ROVOXID-CAPS-10MG-CAP-212-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BIAN-A-E-)



Instance: RAMLET-CAPS-5MG-CAP-213-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(RAMLET-CAPS-5MG-CAP-213-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: RAMLET-CAPS-10MG-CAP-214-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(RAMLET-CAPS-10MG-CAP-214-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: RAMLET-CAPS-10MG-CAP-215-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(RAMLET-CAPS-10MG-CAP-215-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: NORVAGEN-TAB-10MG-TAB-218-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORVAGEN-TAB-10MG-TAB-218-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-STARGEN-E-P-E-)



Instance: AMILOPID-CAPS-5MG-CAP-219-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMILOPID-CAPS-5MG-CAP-219-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BIANEKs-A-E-)



Instance: AMILOPID-CAPS-10MG-CAP-220-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMILOPID-CAPS-10MG-CAP-220-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BIANEKs-A-E-)



Instance: AMLOPEN-CAPS-5MG-CAP-221-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLOPEN-CAPS-5MG-CAP-221-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ELPEN-AE-PhARMAKEUTIKE-BIOMEKhANIA)



Instance: AMLOPEN-CAPS-10MG-CAP-222-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLOPEN-CAPS-10MG-CAP-222-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ELPEN-AE-PhARMAKEUTIKE-BIOMEKhANIA)



Instance: AMLORETIN-CAPS-5MG-CAP-223-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLORETIN-CAPS-5MG-CAP-223-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NATURALIA-A-E-)



Instance: AMLORETIN-CAPS-10MG-CAP-224-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(AMLORETIN-CAPS-10MG-CAP-224-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NATURALIA-A-E-)



Instance: NORMODIN-TAB-5MG-TAB-225-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORMODIN-TAB-5MG-TAB-225-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENEPHARM-AE)



Instance: NORMODIN-TAB-10MG-TAB-226-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORMODIN-TAB-10MG-TAB-226-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENEPHARM-AE)



Instance: TEGRETOL-TAB-200MG-TAB-227-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(TEGRETOL-TAB-200MG-TAB-227-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NOVARTIS-HELLAS-A-E-B-E-)



Instance: TEGRETOL-SYR-100MG-5ML-228-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(TEGRETOL-SYR-100MG-5ML-228-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NOVARTIS-HELLAS-A-E-B-E-)



Instance: TEGRETOL-CO-R-F-C-T-200MG-TAB-229-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(TEGRETOL-CO-R-F-C-T-200MG-TAB-229-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NOVARTIS-HELLAS-A-E-B-E-)



Instance: TEGRETOL-CO-R-F-C-T-400MG-TAB-230-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(TEGRETOL-CO-R-F-C-T-400MG-TAB-230-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NOVARTIS-HELLAS-A-E-B-E-)



Instance: NUROFEN-FOR-CHILDREN-oral-SUSP-100MG-5ML-231-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NUROFEN-FOR-CHILDREN-oral-SUSP-100MG-5ML-231-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-RB-HEALTHCARE-HELLAS-A-E-)



Instance: BRUFEN-F-C-TAB-600MG-TAB-232-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(BRUFEN-F-C-TAB-600MG-TAB-232-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BGP-PROIONTA-M-E-P-E-)



Instance: BRUFEN-C-TAB-200MG-TAB-233-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(BRUFEN-C-TAB-200MG-TAB-233-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BGP-PROIONTA-M-E-P-E-)



Instance: BRUFEN-C-TAB-400MG-TAB-234-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(BRUFEN-C-TAB-400MG-TAB-234-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BGP-PROIONTA-M-E-P-E-)



Instance: ADVIL-C-TAB-200MG-TAB-235-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ADVIL-C-TAB-200MG-TAB-235-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PFIZER-ELLAS-A-E-)



Instance: NUROFEN-C-TAB-200MG-TAB-236-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NUROFEN-C-TAB-200MG-TAB-236-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-REKIT-MPENKIZER-ELLAS-KhEMIKA-ABEE)



Instance: NUROFEN-SOFT-CAPS-200MG-CAP-237-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NUROFEN-SOFT-CAPS-200MG-CAP-237-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-REKIT-MPENKIZER-ELLAS-KhEMIKA-ABEE)



Instance: ALGOFREN-SYR-100MG-5ML-238-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ALGOFREN-SYR-100MG-5ML-238-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-INTERMED-ABEE)



Instance: ALGOFREN-SUPP-500MG-SUP-239-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ALGOFREN-SUPP-500MG-SUP-239-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-INTERMED-ABEE)



Instance: ALGOFREN-F-C-TAB-200MG-TAB-240-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ALGOFREN-F-C-TAB-200MG-TAB-240-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-INTERMED-ABEE)



Instance: ALGOFREN-F-C-TAB-400MG-TAB-241-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ALGOFREN-F-C-TAB-400MG-TAB-241-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-INTERMED-ABEE)



Instance: ALGOFREN-F-C-TAB-600MG-TAB-242-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ALGOFREN-F-C-TAB-600MG-TAB-242-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-INTERMED-ABEE)



Instance: PEDEA-SOL-IV-INF-10MG-2ML-243-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PEDEA-SOL-IV-INF-10MG-2ML-243-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-IPhET-AE)



Instance: NEOPROFEN-SOL-IV-INF-10MG-ML-244-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NEOPROFEN-SOL-IV-INF-10MG-ML-244-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-IPhET-AE)



Instance: LIPOMIN-MEDICAL-PHARMAQUALITY-F-C-TAB-20MG-TAB-245-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOMIN-MEDICAL-PHARMAQUALITY-F-C-TAB-20MG-TAB-245-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDICAL-PHARMAQUALITY-AE)



Instance: LIPOMIN-MEDICAL-PHARMAQUALITY-F-C-TAB-40MG-TAB-246-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOMIN-MEDICAL-PHARMAQUALITY-F-C-TAB-40MG-TAB-246-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDICAL-PHARMAQUALITY-AE)



Instance: STATINUM-MEDICHROM-F-C-TAB-20MG-TAB-247-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STATINUM-MEDICHROM-F-C-TAB-20MG-TAB-247-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDICHROM-A-E-)



Instance: STATINUM-MEDICHROM-F-C-TAB-40MG-TAB-248-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STATINUM-MEDICHROM-F-C-TAB-40MG-TAB-248-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDICHROM-A-E-)



Instance: VERISTIN-F-C-TAB-40MG-TAB-249-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VERISTIN-F-C-TAB-40MG-TAB-249-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-VIOFAR-EPE)



Instance: STAZOR-F-C-TAB-20MG-TAB-250-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STAZOR-F-C-TAB-20MG-TAB-250-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ADEPhARM-M-E-P-E-)



Instance: STAZOR-F-C-TAB-40MG-TAB-251-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STAZOR-F-C-TAB-40MG-TAB-251-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ADEPhARM-M-E-P-E-)



Instance: GLIPAL-F-C-TAB-40MG-TAB-252-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(GLIPAL-F-C-TAB-40MG-TAB-252-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-IASIS-PHARMA)



Instance: SIMVAPROL-F-C-TAB-40MG-TAB-253-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVAPROL-F-C-TAB-40MG-TAB-253-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NOVENDIA-PHARMACEUTICALS-EPE)



Instance: SIMVAPROL-F-C-TAB-40MG-TAB-254-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVAPROL-F-C-TAB-40MG-TAB-254-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NOVENDIA-PHARMACEUTICALS-EPE)



Instance: SIMVALID-F-C-TAB-20MG-TAB-255-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVALID-F-C-TAB-20MG-TAB-255-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-VIVAX-PHARMACEUTICALS-LTD-GREECE)



Instance: LIPOMIN-MEDICAL-PHARMAQUALITY-F-C-TAB-20MG-TAB-256-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOMIN-MEDICAL-PHARMAQUALITY-F-C-TAB-20MG-TAB-256-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDICAL-PHARMAQUALITY-AE)



Instance: LIPOMIN-MEDICAL-PHARMAQUALITY-F-C-TAB-40MG-TAB-257-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOMIN-MEDICAL-PHARMAQUALITY-F-C-TAB-40MG-TAB-257-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDICAL-PHARMAQUALITY-AE)



Instance: LOWCHOLID-F-C-TAB-10MG-TAB-258-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LOWCHOLID-F-C-TAB-10MG-TAB-258-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PLUS-PhARMAKEUTIKE-AE)



Instance: SIMVATIN-F-C-TAB-40MG-TAB-259-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVATIN-F-C-TAB-40MG-TAB-259-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BIOSPRAY-ABEE)



Instance: SIMVATIN-F-C-TAB-40MG-TAB-260-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVATIN-F-C-TAB-40MG-TAB-260-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-D-A-S-T-BIOTECH-PHARM-EPE)



Instance: SIMVATIN-F-C-TAB-40MG-TAB-261-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVATIN-F-C-TAB-40MG-TAB-261-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BIOSPRAY-ABEE)



Instance: SIVINAR-F-C-TAB-20MG-TAB-262-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIVINAR-F-C-TAB-20MG-TAB-262-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ANPhARM-ELLAS-A-E-)



Instance: SIVINAR-F-C-TAB-40MG-TAB-263-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIVINAR-F-C-TAB-40MG-TAB-263-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ANPhARM-ELLAS-A-E-)



Instance: REDUSTEROL-F-C-TAB-20MG-TAB-264-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(REDUSTEROL-F-C-TAB-20MG-TAB-264-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PhOINIKsPhARM-EPE)



Instance: REDUSTEROL-F-C-TAB-40MG-TAB-265-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(REDUSTEROL-F-C-TAB-40MG-TAB-265-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PhOINIKsPhARM-EPE)



Instance: LIPEXAL-F-C-TAB-40MG-TAB-266-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPEXAL-F-C-TAB-40MG-TAB-266-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-INNOVIS-PHARMA-A-E-B-E)



Instance: LIPOREX-F-C-TAB-20MG-TAB-267-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOREX-F-C-TAB-20MG-TAB-267-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENEPHARM-AE)



Instance: SIMVACOR-F-C-TAB-20MG-TAB-268-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVACOR-F-C-TAB-20MG-TAB-268-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-KLEBA-APhBEE)



Instance: SIMVACOR-F-C-TAB-40MG-TAB-269-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVACOR-F-C-TAB-40MG-TAB-269-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-KLEBA-APhBEE)



Instance: PRAVOSTIN-F-C-TAB-20MG-TAB-270-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRAVOSTIN-F-C-TAB-20MG-TAB-270-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MINERBA-PhARMAKEUTIKE-A-E-)



Instance: PRAVOSTIN-F-C-TAB-40MG-TAB-271-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRAVOSTIN-F-C-TAB-40MG-TAB-271-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MINERBA-PhARMAKEUTIKE-A-E-)



Instance: EXTRASTATIN-F-C-TAB-20MG-TAB-272-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(EXTRASTATIN-F-C-TAB-20MG-TAB-272-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-S-J-A-PHARM-EPE)



Instance: EXTRASTATIN-F-C-TAB-40MG-TAB-273-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(EXTRASTATIN-F-C-TAB-40MG-TAB-273-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-S-J-A-PHARM-EPE)



Instance: SOTOVASTIN-F-C-TAB-40MG-TAB-274-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SOTOVASTIN-F-C-TAB-40MG-TAB-274-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BROS-E-P-E-)



Instance: KYMAZOL-F-C-TAB-20MG-TAB-275-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(KYMAZOL-F-C-TAB-20MG-TAB-275-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: KYMAZOL-F-C-TAB-20MG-TAB-276-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(KYMAZOL-F-C-TAB-20MG-TAB-276-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: KYMAZOL-F-C-TAB-40MG-TAB-277-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(KYMAZOL-F-C-TAB-40MG-TAB-277-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-RAFARM-A-E-B-E-)



Instance: NORMOTHERIN-F-C-TAB-20MG-TAB-278-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORMOTHERIN-F-C-TAB-20MG-TAB-278-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-UNI-PHARMA-KLEON-TSETES-PhARMAKEUTIKA-ERGASTER)



Instance: NORMOTHERIN-F-C-TAB-40MG-TAB-279-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NORMOTHERIN-F-C-TAB-40MG-TAB-279-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-UNI-PHARMA-KLEON-TSETES-PhARMAKEUTIKA-ERGASTER)



Instance: LIPOREX-F-C-TAB-20MG-TAB-280-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOREX-F-C-TAB-20MG-TAB-280-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENEPHARM-AE)



Instance: LIPOREX-F-C-TAB-40MG-TAB-281-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOREX-F-C-TAB-40MG-TAB-281-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENEPHARM-AE)



Instance: LIPOREX-F-C-TAB-40MG-TAB-282-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOREX-F-C-TAB-40MG-TAB-282-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENEPHARM-AE)



Instance: STATINAL-C-TAB-20MG-TAB-283-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STATINAL-C-TAB-20MG-TAB-283-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ALET-PHARMACEUTICALS-ABEE)



Instance: STATINAL-C-TAB-20MG-TAB-284-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STATINAL-C-TAB-20MG-TAB-284-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-TEVA-GMBH-GERMANY)



Instance: STATINAL-F-C-TAB-40MG-TAB-285-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STATINAL-F-C-TAB-40MG-TAB-285-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-SPECIFAR-ABEE)



Instance: STASIVA-F-C-TAB-20MG-TAB-286-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STASIVA-F-C-TAB-20MG-TAB-286-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PhARMANEL-PhARMAKEUTIKE-A-E-)



Instance: STASIVA-F-C-TAB-20MG-TAB-287-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STASIVA-F-C-TAB-20MG-TAB-287-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PhARMANEL-PhARMAKEUTIKE-A-E-)



Instance: STASIVA-F-C-TAB-20MG-TAB-288-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STASIVA-F-C-TAB-20MG-TAB-288-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BIAN-A-E-)



Instance: STASIVA-F-C-TAB-40MG-TAB-289-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STASIVA-F-C-TAB-40MG-TAB-289-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BIAN-A-E-)



Instance: STASIVA-F-C-TAB-40MG-TAB-290-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STASIVA-F-C-TAB-40MG-TAB-290-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PhARMANEL-PhARMAKEUTIKE-A-E-)



Instance: ZUROCID-F-C-TAB-20MG-TAB-291-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ZUROCID-F-C-TAB-20MG-TAB-291-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-STARGEN-E-P-E-)



Instance: ZUROCID-F-C-TAB-40MG-TAB-292-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ZUROCID-F-C-TAB-40MG-TAB-292-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-STARGEN-E-P-E-)



Instance: ZUROCID-F-C-TAB-40MG-TAB-293-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ZUROCID-F-C-TAB-40MG-TAB-293-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-STARGEN-E-P-E-)



Instance: VASTATIN-F-C-TAB-40MG-TAB-294-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASTATIN-F-C-TAB-40MG-TAB-294-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-VOCATE-PhARMAKEUTIKE-A-E-)



Instance: GOLDASTATIN-F-C-TAB-40MG-TAB-0--295-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(GOLDASTATIN-F-C-TAB-40MG-TAB-0--295-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PANAGIOTES-LEON-SIA-E-E-)



Instance: GOLDASTATIN-F-C-TAB-40MG-TAB-296-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(GOLDASTATIN-F-C-TAB-40MG-TAB-296-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-LINKER-PHARMACEUTICALS-PANAGIOTES-LEON-SIA-E-E)



Instance: LEPUR-F-C-TAB-20MG-TAB-297-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LEPUR-F-C-TAB-20MG-TAB-297-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ELPEN-AE-PhARMAKEUTIKE-BIOMEKhANIA)



Instance: LEPUR-F-C-TAB-40MG-TAB-298-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LEPUR-F-C-TAB-40MG-TAB-298-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ELPEN-AE-PhARMAKEUTIKE-BIOMEKhANIA)



Instance: PRIACIN-F-C-TAB-20MG-TAB-299-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRIACIN-F-C-TAB-20MG-TAB-299-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDOCHEMIE-HELLAS-AE)



Instance: NEZATIN-F-C-TAB-40MG-TAB-300-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NEZATIN-F-C-TAB-40MG-TAB-300-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GRAMMENIDES-AThANASIOS-TOU-DEMETRIOU)



Instance: VERISTIN-F-C-TAB-20MG-TAB-301-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VERISTIN-F-C-TAB-20MG-TAB-301-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-VIOFAR-EPE)



Instance: SIMVASTATIN-TEVA-F-C-TAB-302-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-TEVA-F-C-TAB-302-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-TEVA-PHARMA-B-V-Haarlem-THE-NETHERLANDS)



Instance: SIMVASTATIN-TEVA-F-C-TAB-20MG-TAB-303-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-TEVA-F-C-TAB-20MG-TAB-303-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-TEVA-PHARMA-B-V-Haarlem-THE-NETHERLANDS)



Instance: SIMVASTATIN-TEVA-F-C-TAB-40MG-TAB-304-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-TEVA-F-C-TAB-40MG-TAB-304-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-TEVA-PHARMA-B-V-Haarlem-THE-NETHERLANDS)



Instance: LIPOPRESS-F-C-TAB-20-MG-TAB-305-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOPRESS-F-C-TAB-20-MG-TAB-305-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-HEREMCO-M-E-P-E-)



Instance: LIPOPRESS-F-C-TAB-40-MG-TAB-306-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOPRESS-F-C-TAB-40-MG-TAB-306-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-HEREMCO-M-E-P-E-)



Instance: ANTICHOL-F-C-TAB-20MG-TAB-307-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ANTICHOL-F-C-TAB-20MG-TAB-307-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-HELP-ABEE)



Instance: ANTICHOL-F-C-TAB-20MG-TAB-308-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ANTICHOL-F-C-TAB-20MG-TAB-308-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-HELP-ABEE)



Instance: ANTICHOL-F-C-TAB-40MG-TAB-309-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ANTICHOL-F-C-TAB-40MG-TAB-309-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-HELP-ABEE)



Instance: ANTICHOL-F-C-TAB-40MG-TAB-310-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ANTICHOL-F-C-TAB-40MG-TAB-310-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-HELP-ABEE)



Instance: RAPTOR-F-C-TAB-20MG-TAB-311-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(RAPTOR-F-C-TAB-20MG-TAB-311-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDITRINA-EPE)



Instance: RAPTOR-F-C-TAB-40MG-TAB-312-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(RAPTOR-F-C-TAB-40MG-TAB-312-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDITRINA-EPE)



Instance: MEDISTATIN-RALDEX-F-C-TAB-40MG-TAB-313-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(MEDISTATIN-RALDEX-F-C-TAB-40MG-TAB-313-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDICHROM-A-E-)



Instance: LIPOZID-F-C-TAB-40MG-TAB-314-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPOZID-F-C-TAB-40MG-TAB-314-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-INNOVACT-A-E-)



Instance: VELKASTATIN-F-C-TAB-20MG-TAB-315-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VELKASTATIN-F-C-TAB-20MG-TAB-315-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BELKA-ELLAS-AEBE)



Instance: VELKASTATIN-F-C-TAB-40MG-TAB-316-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VELKASTATIN-F-C-TAB-40MG-TAB-316-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BELKA-ELLAS-AEBE)



Instance: BEVOSTATIN-F-C-TAB-20MG-TAB-317-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(BEVOSTATIN-F-C-TAB-20MG-TAB-317-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-DESANT)



Instance: BEVOSTATIN-F-C-TAB-40MG-TAB-318-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(BEVOSTATIN-F-C-TAB-40MG-TAB-318-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-DESANT)



Instance: PLACOL-SIMVASTATIN-F-C-TAB-20-MG-TAB-319-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PLACOL-SIMVASTATIN-F-C-TAB-20-MG-TAB-319-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BENNETT-PhARMAKEUTIKE-A-E-)



Instance: PLACOL-SIMVASTATIN-F-C-TAB-40-MG-TAB-320-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PLACOL-SIMVASTATIN-F-C-TAB-40-MG-TAB-320-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BENNETT-PhARMAKEUTIKE-A-E-)



Instance: SIMVALARK-F-C-TAB-40MG-TAB-321-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVALARK-F-C-TAB-40MG-TAB-321-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-EDUOSMOS-E-E-ALEBIZOPOULOS-E-E-)



Instance: IAMASTATIN-F-C-TAB-40MG-TAB-322-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(IAMASTATIN-F-C-TAB-40MG-TAB-322-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-IAMATICA-MON-EPE)



Instance: IAMASTATIN-F-C-TAB-40MG-TAB-323-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(IAMASTATIN-F-C-TAB-40MG-TAB-323-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-IAMATICA-MON-EPE)



Instance: ANTICHOL-F-C-TAB-10MG-TAB-324-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ANTICHOL-F-C-TAB-10MG-TAB-324-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-HELP-ABEE)



Instance: VERITRAT-F-C-TAB-40MG-TAB-325-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VERITRAT-F-C-TAB-40MG-TAB-325-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PhARMEKs-A-E-)



Instance: LUSIMVA-F-C-TAB-40MG-TAB-326-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LUSIMVA-F-C-TAB-40MG-TAB-326-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BALU-AE)



Instance: VASSOR-F-C-TAB-20MG-TAB-327-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASSOR-F-C-TAB-20MG-TAB-327-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PNG-GEROLUMATOS-MENTIKAL-A-E-)



Instance: VASSOR-F-C-TAB-20MG-TAB-328-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASSOR-F-C-TAB-20MG-TAB-328-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PNG-GEROLUMATOS-MENTIKAL-A-E-)



Instance: VASSOR-F-C-TAB-40MG-TAB-329-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASSOR-F-C-TAB-40MG-TAB-329-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PNG-GEROLUMATOS-MENTIKAL-A-E-)



Instance: VASSOR-F-C-TAB-40MG-TAB-330-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASSOR-F-C-TAB-40MG-TAB-330-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PNG-GEROLUMATOS-MENTIKAL-A-E-)



Instance: VASSOR-F-C-TAB-40MG-TAB-331-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASSOR-F-C-TAB-40MG-TAB-331-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PNG-GEROLUMATOS-MENTIKAL-A-E-)



Instance: STATIVER-F-C-TAB-40MG-TAB-332-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STATIVER-F-C-TAB-40MG-TAB-332-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-CROSS-PHARMACEYTICALS-P-C-)



Instance: ANTICHOL-F-C-TAB-40MG-TAB-333-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ANTICHOL-F-C-TAB-40MG-TAB-333-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-HELP-ABEE)



Instance: ANTICHOL-F-C-TAB-20MG-TAB-334-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ANTICHOL-F-C-TAB-20MG-TAB-334-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-HELP-ABEE)



Instance: SIMVASTIL-F-C-TAB-20MG-TAB-335-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTIL-F-C-TAB-20MG-TAB-335-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDARTE-PhARMAKEUTIKE-ABEE)



Instance: SIMVASTIL-F-C-TAB-40MG-TAB-336-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTIL-F-C-TAB-40MG-TAB-336-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDARTE-PhARMAKEUTIKE-ABEE)



Instance: LOWCHOLID-F-C-TAB-20MG-TAB-337-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LOWCHOLID-F-C-TAB-20MG-TAB-337-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NATURALIA-A-E-)



Instance: LOWCHOLID-F-C-TAB-40MG-TAB-338-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LOWCHOLID-F-C-TAB-40MG-TAB-338-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NATURALIA-A-E-)



Instance: IPRAMID-F-C-TAB-20MG-TAB-339-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(IPRAMID-F-C-TAB-20MG-TAB-339-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-FARMEDIA-AE)



Instance: IPRAMID-F-C-TAB-40MG-TAB-340-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(IPRAMID-F-C-TAB-40MG-TAB-340-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-VENIFAR-LTD-CYPRUS)



Instance: SIMVALID-F-C-TAB-40MG-TAB-341-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVALID-F-C-TAB-40MG-TAB-341-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-VIVAX-PHARMACEUTICALS-LTD-GREECE)



Instance: STERYLIP-F-C-TAB-40MG-TAB-342-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STERYLIP-F-C-TAB-40MG-TAB-342-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PHAREL-MONOPROSOPE-IKE)



Instance: SIMVASTATIN-NORMA-F-C-TAB-20MG-TAB-343-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-NORMA-F-C-TAB-20MG-TAB-343-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NORMA-ELLAS-A-E-)



Instance: SIMVASTATIN-NORMA-F-C-TAB-40MG-TAB-344-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-NORMA-F-C-TAB-40MG-TAB-344-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-NORMA-ELLAS-A-E-)



Instance: DOCTIVERINE-F-C-TAB-20MG-TAB-345-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(DOCTIVERINE-F-C-TAB-20MG-TAB-345-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-DOCTUM-PhARMAKEUTIKE-K-GIOKARES-SIA-A-E-)



Instance: DOCTIVERINE-F-C-TAB-40MG-TAB-346-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(DOCTIVERINE-F-C-TAB-40MG-TAB-346-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-DOCTUM-PhARMAKEUTIKE-K-GIOKARES-SIA-A-E-)



Instance: PRIACIN-F-C-TAB-20MG-TAB-347-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRIACIN-F-C-TAB-20MG-TAB-347-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDOCHEMIE-HELLAS-AE)



Instance: PRELON-F-C-TAB-20MG-TAB-348-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRELON-F-C-TAB-20MG-TAB-348-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PhARAN-ABEE-PARAGOGES-KAI-EMPORIAS-PhARMAKON)



Instance: PRELON-F-C-TAB-40MG-TAB-349-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRELON-F-C-TAB-40MG-TAB-349-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-ANGELINI-PHARMA-HELLAS-ABEE)



Instance: SIMVASTEROL-F-C-TAB-40MG-TAB-350-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTEROL-F-C-TAB-40MG-TAB-350-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-LIBYTEC-A-E-)



Instance: LIPEXAL-F-C-TAB-40MG-TAB-351-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIPEXAL-F-C-TAB-40MG-TAB-351-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PhARMATEN-ELLAS-AEBE)



Instance: ZOCOR-F-C-TAB-20MG-TAB-352-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ZOCOR-F-C-TAB-20MG-TAB-352-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BIANEKs-A-E-)



Instance: ZOCOR-F-C-TAB-40MG-TAB-353-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ZOCOR-F-C-TAB-40MG-TAB-353-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BIANEKs-A-E-)



Instance: PRIZELIP-F-C-TAB-40MG-TAB-354-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRIZELIP-F-C-TAB-40MG-TAB-354-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PhERAKON-I-K-E-)



Instance: ARSTATIN-F-C-TAB-20MG-TAB-355-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ARSTATIN-F-C-TAB-20MG-TAB-355-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-DOC-PHARMA-AE)



Instance: ARSTATIN-F-C-TAB-40MG-TAB-356-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ARSTATIN-F-C-TAB-40MG-TAB-356-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-DOC-PHARMA-AE)



Instance: TREMITAL-F-C-TAB-40MG-TAB-357-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(TREMITAL-F-C-TAB-40MG-TAB-357-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BIORESPOND-E-P-E-)



Instance: NEZATIN-F-C-TAB-40MG-TAB-358-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NEZATIN-F-C-TAB-40MG-TAB-358-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-HEREMCO-M-E-P-E-)



Instance: RAVOSTAN-F-C-TAB-20MG-TAB-359-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(RAVOSTAN-F-C-TAB-20MG-TAB-359-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PLA-PHARMACEUTICALS-A-E-)



Instance: RAVOSTAN-F-C-TAB-40MG-TAB-360-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(RAVOSTAN-F-C-TAB-40MG-TAB-360-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PLA-PHARMACEUTICALS-A-E-)



Instance: LIP-DOWN-F-C-TAB-20MG-TAB-361-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIP-DOWN-F-C-TAB-20MG-TAB-361-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-A-KhATZEANTONOGLOU-VELTIPHARM-EPE)



Instance: LIP-DOWN-F-C-TAB-40-MG-TAB-362-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(LIP-DOWN-F-C-TAB-40-MG-TAB-362-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PHARMAZAC-AE)



Instance: NITASTIN-F-C-TAB-20MG-TAB-363-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NITASTIN-F-C-TAB-20MG-TAB-363-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PHARMAZAC-AE)



Instance: NITASTIN-F-C-TAB-40MG-TAB-364-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(NITASTIN-F-C-TAB-40MG-TAB-364-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PHARMAZAC-AE)



Instance: ZOCOR-F-C-TAB-10MG-TAB-365-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(ZOCOR-F-C-TAB-10MG-TAB-365-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-BIANEKs-A-E-)



Instance: SIMVASTATIN-GENERICS-F-C-TAB-10MG-TAB-366-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-GENERICS-F-C-TAB-10MG-TAB-366-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: SIMVASTATIN-GENERICS-F-C-TAB-20MG-TAB-367-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-GENERICS-F-C-TAB-20MG-TAB-367-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: SIMVASTATIN-GENERICS-F-C-TAB-40MG-TAB-368-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-GENERICS-F-C-TAB-40MG-TAB-368-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-GENERICS-PHARMA-HELLAS-EPE)



Instance: STATOSAN-F-C-TAB-20MG-TAB-369-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(STATOSAN-F-C-TAB-20MG-TAB-369-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PHARMAXIA-HELLAS-E-E-)



Instance: PRIACIN-F-C-TAB-10MG-TAB-370-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRIACIN-F-C-TAB-10MG-TAB-370-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDOCHEMIE-HELLAS-AE)



Instance: PRIACIN-F-C-TAB-40MG-TAB-371-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(PRIACIN-F-C-TAB-40MG-TAB-371-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MEDOCHEMIE-HELLAS-AE)



Instance: FLUITIN-F-C-TAB-40MG-TAB-372-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(FLUITIN-F-C-TAB-40MG-TAB-372-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-PHARMALINK)



Instance: VASTATIN-F-C-TAB-20MG-TAB-373-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VASTATIN-F-C-TAB-20MG-TAB-373-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-VOCATE-PhARMAKEUTIKE-A-E-)



Instance: VERISTIN-F-C-TAB-20MG-TAB-374-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(VERISTIN-F-C-TAB-20MG-TAB-374-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-VIOFAR-EPE)



Instance: SIMVASTATIN-MYLAN-F-C-TAB-10MG-TAB-375-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-MYLAN-F-C-TAB-10MG-TAB-375-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MYLAN-S-A-S-SAINT-PRIEST-FRANCE)



Instance: SIMVASTATIN-MYLAN-F-C-TAB-20MG-TAB-376-GRC-RA
InstanceOf: PPLRegulatedAuthorization
Usage: #example

* identifier.value = ""
* subject = Reference(SIMVASTATIN-MYLAN-F-C-TAB-20MG-TAB-376-GRC-MPD)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000406 "Hellenic Republic"
* status = $100000072049#200000017708 "Valid - Renewed/Varied"
//  * statusDate = "2013-06-07"
* holder = Reference(LOC-MYLAN-S-A-S-SAINT-PRIEST-FRANCE)

